We have located links that may give you full text access.
Journal Article
Review
Albumin dialysis: current practice and future options.
Liver International : Official Journal of the International Association for the Study of the Liver 2011 September
The current management of patients with severe liver failure encompasses treatment of the precipitating event and supportive therapy for extra-hepatic end-organ dysfunction while waiting for the liver to recover or for a suitable graft to become available. Molecular Adsorbent Recirculating System (MARS) is an extracorporeal detoxification device that allows the save and effective removal of albumin-bound as well as water-soluble substances in an effort to overcome phases of critical organ dysfunction or to bridge patients until transplantation. MARS has proven to be a useful treatment in patients with acute-on-chronic liver failure and acute liver failure for improving biochemical parameters and clinical symptoms but benefits in patient outcome have not yet been fully demonstrated. The optimal timing for initiation, frequency and duration of MARS treatment, and the biochemical and clinical parameters on which to base clinical decisions, remain partially unanswered issues.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app